Skip NavigationSkip to Content

Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting

  1. Author:
    Agrawal, Mukta
    Saraf, Swarnlata
    Saraf, Shailendra
    Dubey, Sunil Kumar
    Puri,Anu
    Patel, Ravish J.
    Ravichandiran, V.
    Murty, Upadhyayula Suryanarayana
    Alexander, Amit
  2. Author Address

    Rungta Coll Pharmaceut Sci & Res, Kohka Kurud Rd, Bhilai 490024, Chhattisgarh, India.Pt Ravishankar Shukla Univ, Univ Inst Pharm, Raipur 492010, Chhattisgarh, India.BITS PILANI, Dept Pharm, Pilani Campus, Pilani, Rajasthan, India.NCI, RNA Struct & Design Sect, RNA Biol Lab, Ctr Canc Res,NIH, Frederick, MD 21701 USA.Charotar Univ Sci & Technol CHARUSAT, Ramanbhai Patel Coll Pharm, Anand 388421, Gujarat, India.Govt India, Minist Chem & Fertilizers, Natl Inst Pharmaceut Educ & Res NIPER Kolkata, Chunilal Bhawan 168,Maniktala Main Rd, Kolkata 700054, India.Govt India, Natl Inst Pharmaceut Educ & Res NIPER Guwahati, Dept Pharmaceut, Minist Chem & Fertilizers,NITS Mirza, NH 37, Gauhati 781125, Assam, India.
    1. Year: 2020
    2. Date: May 10
    3. Epub Date: 2020 02 12
  1. Journal: Journal of controlled release : official journal of the Controlled Release Society
  2. ELSEVIER,
    1. 321
    2. Pages: 372-415
  3. Type of Article: Review
  4. ISSN: 0168-3659
  1. Abstract:

    In last two decades, the lipid nanocarriers have been extensively investigated for their drug targeting efficiency towards the critical areas of the human body like CNS, cardiac region, tumor cells, etc. Owing to the flexibility and biocompatibility, the lipid-based nanocarriers, including nanoemulsion, liposomes, SLN, NLC etc. have gained much attention among various other nanocarrier systems for brain targeting of bioactives. Across different lipid nanocarriers, NLC remains to be the safest, stable, biocompatible and cost-effective drug carrier system with high encapsulation efficiency. Drug delivery to the brain always remains a challenging issue for scientists due to the complex structure and various barrier mechanisms surrounding the brain. The application of a suitable nanocarrier system and the use of any alternative route of drug administration like nose-to-brain drug delivery could overcome the hurdle and improves the therapeutic efficiency of CNS acting drugs thereof. NLC, a second-generation lipid nanocarrier, upsurges the drug permeation across the BBB due to its unique structural properties. The biocompatible lipid matrix and nano-size make it an ideal drug carrier for brain targeting. It offers many advantages over other drug carrier systems, including ease of manufacturing and scale-up to industrial level, higher drug targeting, high drug loading, control drug release, compatibility with a wide range of drug substances, non-toxic and non-irritant behavior. This review highlights recent progresses towards the development of NLC for brain targeting of bioactives with particular reference to its surface modifications, formulations aspects, pharmacokinetic behavior and efficacy towards the treatment of various neurological disorders like AD, PD, schizophrenia, epilepsy, brain cancer, CNS infection (viral and fungal), multiple sclerosis, cerebral ischemia, and cerebral malaria. This work describes in detail the role and application of NLC, along with its different fabrication techniques and associated limitations. Specific emphasis is given to compile a summary and graphical data on the area explored by scientists and researchers worldwide towards the treatment of neurological disorders with or without NLC. The article also highlights a brief insight into two prime approaches for brain targeting, including drug delivery across BBB and direct nose-to-brain drug delivery along with the current global status of specific neurological disorders.

    See More

External Sources

  1. DOI: 10.1016/j.jconrel.2020.02.020
  2. PMID: 32061621
  3. WOS: 000526179100026

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel